Davis R M Inc. Grows Stock Position in Stryker Co. (NYSE:SYK)

Davis R M Inc. boosted its holdings in Stryker Co. (NYSE:SYK - Free Report) by 3.1% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 109,037 shares of the medical technology company's stock after purchasing an additional 3,295 shares during the quarter. Davis R M Inc.'s holdings in Stryker were worth $32,652,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Duality Advisers LP purchased a new stake in shares of Stryker in the third quarter worth $683,000. Empirical Financial Services LLC d.b.a. Empirical Wealth Management grew its holdings in shares of Stryker by 6.0% during the third quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 757 shares of the medical technology company's stock valued at $207,000 after buying an additional 43 shares during the last quarter. Main Street Financial Solutions LLC bought a new position in Stryker in the 3rd quarter valued at approximately $201,000. Private Advisor Group LLC boosted its stake in Stryker by 1.7% during the 3rd quarter. Private Advisor Group LLC now owns 13,434 shares of the medical technology company's stock valued at $3,670,000 after purchasing an additional 229 shares during the last quarter. Finally, SageView Advisory Group LLC increased its holdings in shares of Stryker by 4.1% in the 3rd quarter. SageView Advisory Group LLC now owns 1,390 shares of the medical technology company's stock worth $380,000 after purchasing an additional 55 shares in the last quarter. 77.09% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other Stryker news, CAO William E. Berry, Jr. sold 7,690 shares of Stryker stock in a transaction on Thursday, March 7th. The shares were sold at an average price of $358.48, for a total transaction of $2,756,711.20. Following the completion of the transaction, the chief accounting officer now directly owns 3,675 shares of the company's stock, valued at $1,317,414. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 5.50% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on SYK. Evercore ISI boosted their price objective on shares of Stryker from $340.00 to $370.00 and gave the company an "outperform" rating in a report on Thursday, April 4th. Canaccord Genuity Group upgraded Stryker from a "hold" rating to a "buy" rating and boosted their price target for the company from $315.00 to $360.00 in a research note on Wednesday, January 31st. StockNews.com upgraded shares of Stryker from a "hold" rating to a "buy" rating in a research note on Tuesday, January 23rd. Barclays boosted their target price on shares of Stryker from $372.00 to $376.00 and gave the company an "overweight" rating in a research report on Thursday, May 2nd. Finally, TD Cowen lifted their price target on shares of Stryker from $365.00 to $400.00 and gave the stock a "buy" rating in a research note on Thursday, April 11th. Four investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $365.94.

Stryker Price Performance

Shares of Stryker stock traded up $0.78 during trading on Tuesday, reaching $330.51. 1,255,710 shares of the stock traded hands, compared to its average volume of 1,333,435. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.71 and a quick ratio of 0.99. The company has a market capitalization of $125.91 billion, a price-to-earnings ratio of 37.73, a P/E/G ratio of 2.61 and a beta of 0.91. Stryker Co. has a 52-week low of $249.98 and a 52-week high of $361.41. The business has a fifty day simple moving average of $341.13 and a two-hundred day simple moving average of $323.29.

Stryker (NYSE:SYK - Get Free Report) last posted its earnings results on Tuesday, April 30th. The medical technology company reported $2.50 EPS for the quarter, beating analysts' consensus estimates of $2.36 by $0.14. Stryker had a return on equity of 23.05% and a net margin of 16.03%. The firm had revenue of $5.24 billion during the quarter, compared to the consensus estimate of $5.10 billion. During the same period in the prior year, the company earned $2.14 EPS. The company's quarterly revenue was up 9.7% compared to the same quarter last year. Sell-side analysts expect that Stryker Co. will post 11.94 EPS for the current year.

Stryker Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 31st. Stockholders of record on Friday, June 28th will be issued a $0.80 dividend. This represents a $3.20 dividend on an annualized basis and a dividend yield of 0.97%. The ex-dividend date is Friday, June 28th. Stryker's dividend payout ratio (DPR) is 36.53%.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.